dapsone and erlotinib hydrochloride

dapsone has been researched along with erlotinib hydrochloride in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Addeo, R; Alaia, C; Boccellino, M; Caraglia, M; Grimaldi, A; Kast, RE; Nicoletti, GF; Quagliuolo, L	1
Consuegra, G; Fernandez-Penas, P; Hui, R; Liu, RC; Zhao, CY	1

Reviews

1 review(s) available for dapsone and erlotinib hydrochloride

Article	Year
The strange connection between epidermal growth factor receptor tyrosine kinase inhibitors and dapsone: from rash mitigation to the increase in anti-tumor activity. Current medical research and opinion, 2016, Volume: 32, Issue:11 Topics: Antineoplastic Agents; Dapsone; ErbB Receptors; Erlotinib Hydrochloride; Exanthema; Humans; Interleukin-8	2016

Other Studies

1 other study(ies) available for dapsone and erlotinib hydrochloride

Article	Year
Epidermal growth factor receptor inhibitor-induced papulopustular eruption successfully treated with low-dose oral dapsone. The Australasian journal of dermatology, 2018, Volume: 59, Issue:3 Topics: Administration, Oral; Carcinoma, Non-Small-Cell Lung; Dapsone; Dose-Response Relationship, Drug; Drug Eruptions; Erlotinib Hydrochloride; Facial Dermatoses; Female; Follow-Up Studies; Humans; Lung Neoplasms; Middle Aged; Scalp Dermatoses; Treatment Outcome	2018

Article

Year

Epidermal growth factor receptor inhibitor-induced papulopustular eruption successfully treated with low-dose oral dapsone.

The Australasian journal of dermatology, 2018, Volume: 59, Issue:3

Topics: Administration, Oral; Carcinoma, Non-Small-Cell Lung; Dapsone; Dose-Response Relationship, Drug; Drug Eruptions; Erlotinib Hydrochloride; Facial Dermatoses; Female; Follow-Up Studies; Humans; Lung Neoplasms; Middle Aged; Scalp Dermatoses; Treatment Outcome

2018